JERSEY CITY, N.J., Sept. 13, 2012 /PRNewswire/ -- Aoxing Pharmaceutical Company, Inc. (NYSE MKT: AXN). In view of the unusual activity today in the market for the common stock of Aoxing Pharmaceutical Company, Inc., the NYSE Euronext has contacted the company in accordance with the Exchange’s usual practice. The company stated that its policy is not to comment on unusual market activity.
CONTACT:
Aoxing Pharmaceutical Company:
646-367-1747
investor.relations@aoxingpharma.com
SOURCE Aoxing Pharmaceutical Company, Inc.
